Table 2 The distribution of nuclear APE1 expression in ovarian, pancreatico biliary, and gastric cancers (primary and neoadjuvant series)
| Â | Ovarian | Pancreatic | Gastric (primary) | Gastric (neo-adjuvant) |
|---|---|---|---|---|
Positive | 97 (71.9%) | 32 (44.4%) | 41 (44.1%) | 16 (34.8) |
Negative | 38 (28.1%) | 40 (55.6%) | 52 (55.9%) | 30 (65.2%) |
Total | 135 (100%) | 72 (100%) | 93 (100%) | 46 (100%) |
